Concepedia

Terry Podoll

TP

11

Publications

1K

Citations

10

H-Index

1993

Active since

Affiliations

Covance (United States)(Current)

University of Washington

AstraZeneca (United States)

Pearson (United States)

Terry Podoll is an author at Covance (United States) specializing in drug discovery, pharmacology, and drug resistance.

Top concepts

Publications per year

1993–2022

11

Publications

11

Use of midazolam as a human cytochrome P450 3A probe: I. In vitro-in vivo correlations in liver transplant patients.

Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 356 citations

Use of midazolam as a human cytochrome P450 3A probe: II. Characterization of inter- and intraindividual hepatic CYP3A variability after liver transplantation.

Kenneth E. Thummel, Danny D. Shen, Terry Podoll et al. · Journal of Pharmacology and Experimental Therapeutics · 1994 · 223 citations

IN VITRO METABOLISM OF CLINDAMYCIN IN HUMAN LIVER AND INTESTINAL MICROSOMES

Michael A. Wynalda, J. Matthew Hutzler, Michael D. Koets et al. · Drug Metabolism and Disposition · 2003 · 101 citations

Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1.

Kenneth E. Thummel, Evan D. Kharasch, Terry Podoll et al. · Drug Metabolism and Disposition · 1993 · 87 citations

Bioavailability, Biotransformation, and Excretion of the Covalent Bruton Tyrosine Kinase Inhibitor Acalabrutinib in Rats, Dogs, and Humans

Terry Podoll, Paul G. Pearson, Jerry Evarts et al. · Drug Metabolism and Disposition · 2018 · 67 citations · Full text

Rows per page

1–5 of 11